Cargando…
Serum markers of cardiac complications in a systemic sclerosis cohort
Primary cardiac involvement is one of the leading causes of mortality in systemic sclerosis (SSc), but little is known regarding circulating biomarkers for cardiac SSc. Here, we aimed to investigate potential associations between cardiac SSc and candidate serum markers. Serum samples from patients o...
Autores principales: | Tennøe, Anders H., Murbræch, Klaus, Didriksen, Henriette, Ueland, Thor, Palchevskiy, Vyacheslav, Weigt, Stephen S., Fretheim, Håvard, Midtvedt, Øyvind, Garen, Torhild, Brunborg, Cathrine, Aukrust, Pål, Molberg, Øyvind, Belperio, John A., Hoffmann-Vold, Anna-Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933514/ https://www.ncbi.nlm.nih.gov/pubmed/35304587 http://dx.doi.org/10.1038/s41598-022-08815-8 |
Ejemplares similares
-
Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension
por: Didriksen, Henriette, et al.
Publicado: (2022) -
Systolic Dysfunction in Systemic Sclerosis: Prevalence and Prognostic Implications
por: Tennøe, Anders H., et al.
Publicado: (2019) -
Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort
por: Fretheim, Håvard, et al.
Publicado: (2020) -
Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial
por: Fretheim, Håvard, et al.
Publicado: (2020) -
Augmented concentrations of CX(3)CL1 are associated with interstitial lung disease in systemic sclerosis
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2018)